ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,215
Diagnostic referrals
999
Outstanding pathways
332

Screening pathway

  1. Screening5,215Encounters
  2. Positive finding1,814Documented findings
  3. Referral999Diagnostic referrals
  4. Follow-up1,211Diagnostic visits
  5. Outcome667Resolved pathways

Stage totals use different units. Pending pathways: 332. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2027-03-12, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate
  19. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  20. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0001 · Expanded synthetic participant 0001Site E — Resource-Constrained Navigation Programme
EXP-0002 · Expanded synthetic participant 0002Site C — Rural Outreach Programme
EXP-0003 · Expanded synthetic participant 0003Site A — Urban Referral Hub
EXP-0004 · Expanded synthetic participant 0004Site E — Resource-Constrained Navigation Programme
EXP-0005 · Expanded synthetic participant 0005Site B — Peri-Urban Access Programme
EXP-0006 · Expanded synthetic participant 0006Site E — Resource-Constrained Navigation Programme
EXP-0007 · Expanded synthetic participant 0007Site C — Rural Outreach Programme
EXP-0008 · Expanded synthetic participant 0008Site B — Peri-Urban Access Programme
EXP-0009 · Expanded synthetic participant 0009Site E — Resource-Constrained Navigation Programme
EXP-0011 · Expanded synthetic participant 0011Site B — Peri-Urban Access Programme
EXP-0012 · Expanded synthetic participant 0012Site A — Urban Referral Hub
EXP-0013 · Expanded synthetic participant 0013Site D — Community Engagement Programme
EXP-0014 · Expanded synthetic participant 0014Site E — Resource-Constrained Navigation Programme
EXP-0015 · Expanded synthetic participant 0015Site D — Community Engagement Programme
EXP-0016 · Expanded synthetic participant 0016Site C — Rural Outreach Programme
EXP-0017 · Expanded synthetic participant 0017Site D — Community Engagement Programme
EXP-0018 · Expanded synthetic participant 0018Site E — Resource-Constrained Navigation Programme
EXP-0019 · Expanded synthetic participant 0019Site C — Rural Outreach Programme
EXP-0020 · Expanded synthetic participant 0020Site C — Rural Outreach Programme
EXP-0021 · Expanded synthetic participant 0021Site B — Peri-Urban Access Programme
EXP-0022 · Expanded synthetic participant 0022Site B — Peri-Urban Access Programme
EXP-0023 · Expanded synthetic participant 0023Site D — Community Engagement Programme
EXP-0025 · Expanded synthetic participant 0025Site B — Peri-Urban Access Programme
EXP-0026 · Expanded synthetic participant 0026Site B — Peri-Urban Access Programme
EXP-0027 · Expanded synthetic participant 0027Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1957
HPV DNA
2539
Cytology
719

Navigation activity

Barrier documented
907
Contact attempt
1458
Navigation intervention
397
Diagnostic booking
1256
Diagnostic visit
1211

Documented barriers

Contact difficulty
291
Transport difficulty
299
Appointment coordination
317

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.